BlackRock Fund Advisors’s Collegium Pharmaceutical COLL Stock Holding History

BlackRock Fund Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$14.5M	Buy	931,081 +237,026	+34%	+$3.94M	﹤0.01%	2362
2016 Q3	$13.4M	Buy	694,055 +43,581	+7%	+$518K	﹤0.01%	2298
2016 Q2	$7.71M	Buy	650,474 +147,461	+29%	+$2.44M	﹤0.01%	2558
2016 Q1	$9.13M	Buy	503,013 +84,819	+20%	+$1.54M	﹤0.01%	2411
2015 Q4	$11.5M	Buy	418,194 +243,639	+140%	+$5.13M	﹤0.01%	2363
2015 Q3	$3.86M	Sell	174,555 -2,421	-1%	-$43.8K	﹤0.01%	2928
2015 Q2	$3.16M	Buy	+176,976	New	+$3.06M	﹤0.01%	3091

Other funds holding COLL

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return